FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...

A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and treating atrial ...

Less than a week after he shared the inauguration stage with a senior Catholic cardinal, Vice President JD Vance picked a fight with the top American leaders of his church.

The global laser-assisted ENT surgery market Share is projected to grow from US$ 254.14 million in 2023 to US$ 513.78 million ...

Health, education, transport and law and order are still important, but Prime Minister Christopher Luxon is travelling the ...

Advanced Fertility Center of Chicago (AFCC), a premier provider of comprehensive and best-in-class fertility services, congratulates Dr. Michelle Catenacci on being named a 2025 Castle Connolly Top ...

More than eight years ago, the Government promised us a new healthcare hub for the South. A hub that was supposed to start operating in 2020, but which is still not functioning, the Nationalist Party ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Scientists from The University of Texas Health Science Center at San Antonio have discovered a potential new drug that could ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Snoring affects billions of people worldwide and can be a sign of serious health problems like sleep apnea. Learn about the risks, prevalence, and treatment options for this common issue.